J.W. CHILDS ASSOCIATES, L.P.
- Company typePrivate
- Founded1995
- HeadquartersBoston, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
J.W. CHILDS ASSOCIATES, L.P. firmographics
Firmographics- Name
- J.W. CHILDS ASSOCIATES, L.P.
- Legal name
- J.W. Childs Associates, FL L.P.
- Website
- https://jwchilds.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
J.W. CHILDS ASSOCIATES, L.P. industry classification
Industry- Product category
- Venture Capital and Private Equity Investment Services
- NAICS
- Portfolio Management and Investment Advice (523940), All Other Financial Investment Activities (52399)
- SIC
- Investment Advice (6282), Investors, Nec (6799)
- akta.pro primary industry
- Family Office Investment Platforms & Direct Investing (PE/VC/Co-Invest) (FSAAADAH)
Keywords
Where J.W. CHILDS ASSOCIATES, L.P. is headquartered
LocationHeadquarters
- HQ city
- Boston
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
J.W. CHILDS ASSOCIATES, L.P. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Investment Returns: Returns generated through equity stakes in portfolio companies. The firm builds significant equity positions as early investors and plays an active role in company development, with the goal of realizing gains through exits.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
J.W. CHILDS ASSOCIATES, L.P. product offering
Product offeringCore offering
J.W. Childs Associates is a private equity and venture capital investment firm that deploys capital through direct equity investments in companies, co-investments alongside external managers, and fund investments in partner managers. It focuses on Series A and early-round investments in clinical-stage biotechnology, pharmaceutical, and healthcare consumer product companies addressing large unmet medical needs. The firm seeks to build significant equity stakes and play an active role in portfolio company development through board participation and strategic guidance.
Product overview
J.W. Childs Associates, FL L.P. is a 31-year-old private equity and venture capital investment firm that today focuses on venture capital investments in biotechnology, pharmaceuticals, and healthcare consumer products. The firm offers investment services through direct investments in companies, co-investments alongside external managers, and investments in the funds of investment managers regarded as partners. Their portfolio includes clinical-stage companies such as VeraDermics Inc. (dermatology/hair loss treatment), Biohaven Ltd. (neurosciences/immunology), Garuda Therapeutics (stem cells), and Osmol Therapeutics (neurosciences).
Differentiator
Problem solved
Functional benefit
Products and services
- Venture Capital and Private Equity Investment Services Direct venture capital and private equity investments in clinical-stage biotechnology, pharmaceutical, and healthcare consumer product companies, typically as Series A or early-round investors building significant equity stakes and playing active roles via board participation; plus co-investments alongside external managers and fund-of-fund investments in partner managers. Target audience is clinical-stage life sciences companies and healthcare consumer product companies seeking equity capital and strategic guidance.
Companies that use J.W. CHILDS ASSOCIATES, L.P.
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
J.W. CHILDS ASSOCIATES, L.P. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
J.W. CHILDS ASSOCIATES, L.P. partnerships and signals
Strategic signalScale indicators2 records
Recent moves4 records
Expansion highlights3 records
J.W. CHILDS ASSOCIATES, L.P. competitors and assessment
Company assessmentDirect peers
- Versant Ventures: Healthcare-focused venture capital firm investing across biotech, medical devices, and healthcare services. Comparable for early-stage clinical asset investing with active company-building involvement.
- RA Capital Management: Healthcare-focused investment firm combining public and private biotech investing with dedicated crossover and venture funds. Comparable for early-stage biotech investing and active board participation.
- 5AM Ventures: Early-stage venture capital firm focused on life sciences, including biotech and platform technologies. Comparable as a smaller, science-driven biotech VC investing at Series A and earlier stages.
- Frazier Healthcare Partners: Healthcare-dedicated investment firm investing across biopharma, medtech, and healthcare services at multiple stages. Comparable as a long-tenured, healthcare-specialized PE/VC with active portfolio development.
- Atlas Venture: Early-stage biotech venture capital firm that builds and funds breakthrough therapeutics, often from inception. Comparable as a Series A-focused biotech VC investing in clinical assets in large unmet-need markets.
- SR One (GlaxoSmithKline): Healthcare and biotech venture capital firm investing in early-stage therapeutics companies. Comparable as a biotech-focused VC with significant equity positions and active development support.
- Perceptive Advisors: Healthcare-focused investment firm with both public and private strategies across biotech, medtech, and healthcare services. Comparable for early-stage biotech venture investing alongside a broader life-sciences platform.
- OrbiMed Advisors: One of the largest dedicated healthcare/biotech investment firms, making direct venture and growth investments in biopharmaceuticals, medical devices, and diagnostics. Directly comparable as a life-sciences-focused PE/VC with a multi-strategy platform.
- New Leaf Venture Partners: Healthcare-focused venture capital firm investing in clinical-stage biopharmaceutical and medical device companies. Comparable for therapeutic-area focus and active board involvement.
Broad incumbents
- Blackstone Life Sciences: Large, broad private equity platform with a dedicated life sciences franchise backing clinical-stage therapeutics and healthcare companies. Comparable as a much larger healthcare investor with overlapping therapeutic focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
J.W. CHILDS ASSOCIATES, L.P. financial estimates
Financial estimateRevenue estimate
Valuation estimate
J.W. CHILDS ASSOCIATES, L.P. leadership team
Management profileNumber of profiles
Profiles2 records
J.W. CHILDS ASSOCIATES, L.P. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
J.W. CHILDS ASSOCIATES, L.P. M&A and investment
M&A and investmentM&A
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about J.W. CHILDS ASSOCIATES, L.P.
What does J.W. CHILDS ASSOCIATES, L.P. do?
J.W. Childs Associates is a private equity and venture capital investment firm that deploys capital through direct equity investments in companies, co-investments alongside external managers, and fund investments in partner managers. It focuses on Series A and early-round investments in clinical-stage biotechnology, pharmaceutical, and healthcare consumer product companies addressing large unmet medical needs. The firm seeks to build significant equity stakes and play an active role in portfolio company development through board participation and strategic guidance.
Is J.W. CHILDS ASSOCIATES, L.P. a public or private company?
J.W. CHILDS ASSOCIATES, L.P. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was J.W. CHILDS ASSOCIATES, L.P. founded?
J.W. CHILDS ASSOCIATES, L.P. was founded in 1995. It employs 11 to 50 people.
Where is J.W. CHILDS ASSOCIATES, L.P. based?
J.W. CHILDS ASSOCIATES, L.P. is headquartered in Boston, United States, in the North America region.
How does J.W. CHILDS ASSOCIATES, L.P. make money?
One revenue line is on record: investment Returns.
Who are J.W. CHILDS ASSOCIATES, L.P.'s main competitors?
Direct peers on record are Versant Ventures, RA Capital Management, 5AM Ventures, Frazier Healthcare Partners, Atlas Venture, SR One (GlaxoSmithKline), Perceptive Advisors, OrbiMed Advisors and New Leaf Venture Partners. Blackstone Life Sciences is listed as a broad incumbent.
Does J.W. CHILDS ASSOCIATES, L.P. have an API?
No public API is recorded for J.W. CHILDS ASSOCIATES, L.P..
What industry is J.W. CHILDS ASSOCIATES, L.P. in?
J.W. CHILDS ASSOCIATES, L.P.'s product category is Venture Capital and Private Equity Investment Services. Its primary akta.pro industry code is FSAAADAH, Family Office Investment Platforms & Direct Investing (PE/VC/Co-Invest). Its NAICS code is 523940 and its SIC code is 6282.